Page results
-
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
-
The maternity team at UCLH will listen to your hopes and concerns and can suggest helpful and practical ideas to help you.
-
A drop-in service providing support, practical advice and information.
-
The service offers psychotherapeutic intervention for women receiving ante-natal and post-natal care at UCLH, their partners, and their children in the event of perinatal loss.
-
Find and Treat screen tens of thousands of the most vulnerable, homeless and high-risk people every year using mobile units deployed from UCLH.
-
This page answers common questions about high-intensity focused ultrasound (HIFU) treatment for the prostate.
-
We run dedicated follow up clinics for brain injured patients, either following discharge from hospital or the emergency department.
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
-
The molecular genetics laboratory at UCLH is a national centre for the genetic diagnosis of haemoglobin disorders, including prenatal diagnosis.
-
Parenteral Nutrition, also know as PN, is used to feed extremely premature or unwell babies.
File results
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0540 - Electronic patient record
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm
-
FOI/2022/0576 - Medications within dermatology